Figure 8 Investment Strategies LLC Invests $1.24 Million in Danaher Corporation $DHR

Figure 8 Investment Strategies LLC purchased a new position in Danaher Corporation (NYSE:DHR) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 6,499 shares of the conglomerate’s stock, valued at approximately $1,238,000.

Several other institutional investors have also recently added to or reduced their stakes in DHR. BlackRock Inc. bought a new stake in shares of Danaher in the 2nd quarter worth about $10,492,520,000. State Street Corp lifted its position in shares of Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after purchasing an additional 472,608 shares during the last quarter. Capital International Investors grew its stake in Danaher by 8.9% in the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after purchasing an additional 1,487,768 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in Danaher by 9.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after purchasing an additional 1,334,221 shares in the last quarter. Finally, Wellington Management Group LLP increased its holdings in Danaher by 11.2% in the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after buying an additional 1,517,904 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on DHR. Piper Sandler assumed coverage on Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective on the stock. TD Cowen lowered their price target on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. HSBC dropped their price target on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Finally, Stifel Nicolaus decreased their price objective on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Danaher Trading Down 1.5%

NYSE:DHR opened at $199.62 on Wednesday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The firm has a market capitalization of $140.33 billion, a P/E ratio of 35.46, a P/E/G ratio of 2.52 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The business has a 50 day simple moving average of $193.74 and a 200 day simple moving average of $192.50.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.77 EPS. Equities research analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.